Status:
UNKNOWN
Sublingual Misoprostol and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section
Lead Sponsor:
Aswan University Hospital
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Purpose to evaluate the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women with twin pre...
Detailed Description
Uterine atony is the major cause of postpartum hemorrhage (PPH), accounting for up to 80% of PPH cases. PPH is the leading cause of maternal morbidity and mortality worldwide, resulting in up to 28% o...
Eligibility Criteria
Inclusion
- women with a multiple term pregnancy undergoing elective cesarean section
Exclusion
- single gestation
- placenta praevia and placental abruption
- undergoing cesarean section with general anesthesia
- women undergoing cesarean section at less than 37 weeks of gestation
- with a severe medical disorder
- allergy to tranexamic acid or misoprostol
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03774524
Start Date
January 1 2019
End Date
March 1 2021
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University
Aswān, Egypt, 81528